Children's Hospital of Wisconsin
Milwaukee, Wisconsin, 53226, United States
NCT Number: NCT02593903
The purpose of this study is to evaluate the efficacy of prophylactic antibiotics following distal or mid-shaft hypospadias repair in influencing the rate of postoperative urinary tract infection and complications.
Looking for future studies?
Notify Me6 month–2 year
Male
Interventional
Not applicable
Milwaukee, Wisconsin, 53226, United States
The rationale for using prophylactic antibiotics after hypospadias surgery is to decrease the occurrence of urinary tract infections (UTIs) and complications. However, even though prophylactic antibiotics are used by some pediatric urologists, to date there has been no evidence supporting the role of prophylactic antibiotics in decreasing UTIs or complications. This is a prospective, randomized trial involving children undergoing distal or mid-shaft hypospadias repair. Subjects randomized into a group taking prophylactic dosages of antibiotics and a group not receiving post-operative antibiotics.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Bactrim, Sulfamethoxazole/trimethoprim
Time frame: 4-8 days post-operation
Urinary tract infection (UTI) will be diagnosed based on urine culture positive at 50,000CFUs per mL with one or both of the following: fever >38 Celsius, or significant fussiness and irritability with voiding per parent report. Asymptomatic bacteriuria is known and expected in this population; therefore culture positive results alone will not be sufficient to meet the definition of UTI.
Medical College of Wisconsin
Other
Prophylactic Antibiotics Following Distal/Mid-shaft Hypospadias Repair: Are They Necessary?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07615335
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Kafr ash Shaykh, Egypt
View Trial DetailsNCT07575204
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Dhaka, Bangladesh
View Trial DetailsNCT07525570
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mardan, KPK, Pakistan
View Trial DetailsNCT07495176
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Shanghai, China
View Trial Details